Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422889 · ClinicalTrials.gov registry record
ION US Post-Approval Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 1,120
- Enrollment target
NCT01422889 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,120 participants.
The verdict
NCT01422889 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 1,120 participants
- Enrollment target
Study Summary
The purpose of this study is to compile real-world clinical outcomes data for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System in routine clinical practice.
Interventions
- DEVICE ION™ Coronary Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,120 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01422889
The ClinicalTrials.gov registry entry for NCT01422889 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ION™ Coronary Stent System is the first listed.
NCT01422889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01422889 about?
NCT01422889 is a clinical study titled "ION US Post-Approval Study". The purpose of this study is to compile real-world clinical outcomes data for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System in routine clinical practice.
What is the current status of trial NCT01422889?
This trial is currently completed. The enrollment target is 1,120 participants. The study started on 2011-09. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01422889?
The interventions under investigation include: ION™ Coronary Stent System (DEVICE).
Who is sponsoring clinical trial NCT01422889?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.